JESSICA JOHNSON: Open Payments
NPI 1982020160 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 14 payments from 11 companies in 2025. Trend: 2023 $614 · 2024 $421 · 2025 $434
Food & beverage: $245Education: $189
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $211 |
| MILLICENT US INC | 2 | $35 |
| Biogen, Inc. | 1 | $25 |
| Stryker Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Exeltis, USA Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Organon LLC | 1 | $20 |
| CooperSurgical, Inc. | 1 | $20 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $19 |
Products named: FEMLYV, ZURZUVAE, CLOTTRIEVER BOLD CATHETER, Kyleena, Veozah, SLYND, QULIPTA, NEXPLANON.
Industry payments across VA — which companies pay providers there.
